SINGAPORE, Dec. 9, 2025 /PRNewswire/ -- Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company developing proprietary water-soluble fullerene-based catalytic antioxidant materials....
Hence then, the article about immortal dragons backs etheros pharmaceuticals targeting aging related disease with breakthrough catalytic antioxidants was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants )
Also on site :
- AMD acquires startup cofounded by ‘godmother of AI’ Fei-Fei Li for $8.2 billion
- Fans Spot a Major Change to Taylor Swift’s ‘The Man’ Music Video During VMA Presentation — Easter Egg or Editing Error?
- In 2012, ‘Glee’ star Dianna Agron paid $1.05 million for a 1920s Hollywood Hills house; she sold it in 2016, and it is now listed at $2.7 million